Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Junchao Cai, … , Jueheng Wu, Mengfeng Li
Junchao Cai, … , Jueheng Wu, Mengfeng Li
Published January 16, 2013
Citation Information: J Clin Invest. 2013;123(2):566-579. https://doi.org/10.1172/JCI65871.
View: Text | PDF
Research Article Oncology

MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis

  • Text
  • PDF
Abstract

Tumor metastasis involves a series of biological steps during which the tumor cells acquire the ability to invade surrounding tissues and survive outside the original tumor site. During the early stages, the cancer cells undergo an epithelial-mesenchymal transition (EMT). Wnt/β-catenin signaling is known to drive EMT and metastasis. Here we report that Wnt/β-catenin signaling is hyperactivated in metastatic breast cancer cells that express microRNA 374a (miR-374a). In breast cancer cell lines, ectopic overexpression of miR-374a promoted EMT and metastasis both in vitro and in vivo. Furthermore, miR-374a directly targeted and suppressed multiple negative regulators of the Wnt/β-catenin signaling cascade, including WIF1, PTEN, and WNT5A. Notably, miR-374a was markedly upregulated in primary tumor samples from patients with distant metastases and was associated with poor metastasis-free survival. These results demonstrate that miR-374a maintains constitutively activated Wnt/β-catenin signaling and may represent a therapeutic target for early metastatic breast cancer.

Authors

Junchao Cai, Hongyu Guan, Lishan Fang, Yi Yang, Xun Zhu, Jie Yuan, Jueheng Wu, Mengfeng Li

×

Figure 6

WIF1, PTEN, and WNT5A are functionally involved in miR-374a–induced invasion and TCF/LEF transcriptional activity of breast cancer cell lines.

Options: View larger image (or click on image) Download as PowerPoint
WIF1, PTEN, and WNT5A are functionally involved in miR-374a–induced inva...
(A) WB analysis confirming the transfection of WIF1-, PTEN-, or WNT5A-targeting siRNAs in MCF7 and 4T1 cells. (B) Quantification of invading MCF7 and 4T1 cells transfected with indicated siRNAs. (C) Luciferase assay of TCF/LEF transcriptional activity in MCF7 and 4T1 cells transfected with indicated siRNAs. (D) Ectopic expression of WIF1, PTEN, or WNT5A in indicated cells was confirmed by WB analysis using GAPDH as a loading control. (E) Quantification of invading cells impacted by overexpression of WIF1, PTEN, or WNT5A in Transwell assay. (F) Luciferase assay of TCF/LEF transcriptional activity in indicated cells. (G) WB analysis confirmed the transfection of specific siRNAs in miR-374a–silenced cells. (H) Quantification of indicated invading cells with specific siRNA transfection. (I) Luciferase assay of TCF/LEF transcriptional activity in indicated cells transfected with specific siRNA. Error bars in B, C, E, F, H, and I represent mean ± SD from 3 independent experiments. *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts